NEW YORK (GenomeWeb News) – This week, several companies involved in the molecular tools and diagnostics space presented at the UBS Global Life Sciences Conferences held here. While GenomeWeb Daily News covered some of those firms in separate articles on Monday through Wednesday, below is a summary of what some of the other firms had to say at the conference.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.